Detalhe da pesquisa
1.
Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains.
J Am Pharm Assoc (2003)
; 64(1): 71-78, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863398
2.
Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire.
J Am Pharm Assoc (2003)
; 63(1): 330-335.e1, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369076
3.
"Like it was just everyday business": A qualitative study of pharmacy-based naloxone and syringe customer experience.
J Am Pharm Assoc (2003)
; 63(3): 838-846, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872182
4.
Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician.
J Am Pharm Assoc (2003)
; 63(1): 284-294.e1, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36567216
5.
Readiness of community pharmacies to implement an opioid safety intervention.
J Am Pharm Assoc (2003)
; 63(1): 275-283.e1, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36496310
6.
Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies.
Subst Abus
; 43(1): 901-905, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213293
7.
The Cost of Safe Injection: Insights on Nonprescription Syringe Price Variability From Systematic Secret Shopping.
Subst Use Addctn J
; 45(2): 201-210, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258818
8.
Factors Associated With Self-reported Use of Web and Mobile Health Apps Among US Military Veterans: Cross-sectional Survey.
JMIR Mhealth Uhealth
; 10(12): e41767, 2022 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36583935